Taken together, these observations suggest that functional impairments of MeCP2 favour the establishment of both constipation and adaptation of an intestinal dysbiotic microbial community that may reinforce the constipation status through non-physiological levels of SCFAs. This evidence concerns the gene MECP2 and constipation disorder.